GLENMARK PHARMACEUTICALS
|
The Current P/S Ratio of GLENMARK PHARMACEUTICALS is 3.10.
Share Price | ₹1,443.3 | May 14,2025 |
Market Cap | ₹40,729.9 Cr | |
Sales-TTM | ₹13,128.5 Cr | TTM-Consolidated Results |
Price/Sales | 3.10x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹40,729.9 Cr] as on May 14,2025
(/) Sales [ ₹13,128.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.10x ]
Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '3.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLENMARK PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK PHARMACEUTICALS
PS Ratio Performance Analysis for GLENMARK PHARMACEUTICALS
- GLENMARK PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- GLENMARK PHARMACEUTICALS 's operated at median p/e ratio of 1.13x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.29x.
- GLENMARK PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.55x.
How does GLENMARK PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK PHARMACEUTICALS | 13,128.5 | 3.10 | 40,729.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.94 | 409,818.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 18.13 | 164,628.0 |
CIPLA LTD | 27,547.6 | 4.38 | 120,775.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.71 | 109,758.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.12 | 101,791.0 |
MANKIND PHARMA LTD | 11,641.0 | 9.04 | 105,255.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.09 | 90,963.5 |
LUPIN LTD | 22,001.6 | 4.30 | 94,611.0 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.29 | 70,834.6 |
ABBOTT INDIA LTD | 6,243.2 | 10.33 | 64,488.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.29x |
Max industry PS | 18.13x |
Median industry PS | 4.38x |
Average industry PS | 6.95x |
You may also like the below Video Courses